Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
– Overenrolled CANYON and advanced the global pivotal cohort, GRAND CANYON, of EDG-5506 in Becker muscular dystrophy –
– Advanced Phase 2 LYNX trial of EDG-5506 including new cohort for boys.
While Valentine’s Day may have passed, the spirit of love continues to flourish throughout February, especially here at Henry Mayo Hospital, where we're dedicated to celebrating matters of the heart in more ways than one! Beyond the chocolates and flowers, we're focusing on maintaining heart health for ourselves and our loved ones.
First Quarter 2023 Reflected Continued Strong Underlying Performance Across Key Growth Drivers, Particularly in Oncology and Vaccines
Total Worldwide Sales Were $14.5 Billion, a Decrease of 9%. | April 27, 2023